DDW 2022, News
Concomitant PPI and Advanced Therapy Linked to Worse Outcomes in IBD
A team of investigators evaluated the effects of concomitant use of PPIs and advanced therapy on health care resources in patients with IBD.
Your search for proton pump inhibitor returned 9 results
News
Dupixent Gets FDA Approval for Eosinophilic Esophagitis
The approval was based on efficacy and safety data from a phase 3 trial, which included two 24-week treatment periods in patients 12 years of age and older with EoE.
Drugs in the Pipeline
Vonoprazan NDA Submitted for Erosive Esophagitis
The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.
News
ASN: PPI Use May Up Risk for AKI After Cardiac Surgery
Adults receiving proton pump inhibitors have increased risk for acute kidney injury requiring dialysis following cardiac surgery
News
Statin Initiation Linked to Greater Progression of Diabetes
Each individual component of the composite outcome was significantly higher among statin users
News
PPI Use May Increase Risk of Community-Acquired Pneumonia
Increased incidence of CAP was noted in stroke patients using PPIs.
News
Cinacalcet Does Not Up Risk for Severe Gastrointestinal Bleeding in Hemodialysis
Study is the largest to explore this potential safety issue to date.
News
Bylvay Approved for Progressive Familial Intrahepatic Cholestasis
Bylvay is an oral reversible inhibitor of the ileal bile acid transporter.
News
Non-Antimicrobial Drugs Tied to Drug-Resistant Bacterial Infection
Proton pump inhibitors, beta-blockers, antimetabolites linked to infection with antibiotic-resistant bacteria
